Fulgent Genetics (FLGT) Other Accumulated Expenses (2016 - 2026)

Fulgent Genetics has disclosed Other Accumulated Expenses across 8 years of filings, most recently posting $2.5 million for Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $2.5 million, down 42.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (down 42.04% YoY), and the FY2025 annual result was $2.8 million, down 21.66% from the prior year.
• Other Accumulated Expenses came in at $2.5 million for Q1 2026 at Fulgent Genetics, down from $2.8 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $13.6 million in Q3 2022 to a low of $281000.0 in Q3 2023.
• The 5-year median for Other Accumulated Expenses is $3.6 million (2024), against an average of $3.7 million.
• Across the five-year window, Other Accumulated Expenses plunged 97.94% in 2023 and surged 1345.55% in 2024, its largest moves.
• Fulgent Genetics' Other Accumulated Expenses stood at $2.1 million in 2022, then jumped by 97.52% to $4.2 million in 2023, then fell by 13.78% to $3.6 million in 2024, then fell by 21.66% to $2.8 million in 2025, then dropped by 13.07% to $2.5 million in 2026.
• The last three Other Accumulated Expenses figures came in at $2.5 million (Q1 2026), $2.8 million (Q4 2025), and $6.9 million (Q3 2025), per Business Quant data.